These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial. Pleasants E, Tauya T, Reddy K, Mirembe BG, Woeber K, Palanee-Phillips T, Zimba C, Atujuna M, Montgomery ET, MTN-020/ASPIRE Study Team. AIDS Behav; 2020 Mar; 24(3):866-880. PubMed ID: 31111297 [Abstract] [Full Text] [Related]
3. "The state of mind tells me it's dirty": menstrual shame amongst women using a vaginal ring in Sub Saharan Africa. Duby Z, Katz A, Musara P, Nabukeera J, Zimba CC, Woeber K, Palanee-Phillips T, van der Straten A. Women Health; 2020 Jan; 60(1):72-86. PubMed ID: 31043134 [Abstract] [Full Text] [Related]
5. Acceptability of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) during Pregnancy in Malawi, South Africa, Uganda, and Zimbabwe. Young AM, Stoner MCD, Mathebula F, Mohuba R, Baez A, Seyama L, Mutero P, Etima J, Fabiano Z, Fairlie L, Mayo AJ, Balkus JE, Song M, Bunge K, Piper J, Balan IC, van der Straten A, Montgomery ET. AIDS Behav; 2024 Nov; 28(11):3615-3628. PubMed ID: 39052199 [Abstract] [Full Text] [Related]
7. Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa. Leslie J, Kiweewa F, Palanee-Phillips T, Bunge K, Mhlanga F, Kamira B, Baeten J, Katz A, Hillier S, Montgomery E, MTN-020/ASPIRE Study Team. BMC Womens Health; 2021 Apr 23; 21(1):175. PubMed ID: 33892693 [Abstract] [Full Text] [Related]
10. Men's Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe. Montgomery ET, Katz AWK, Duby Z, Mansoor LE, Morar NS, Naidoo K, Tsidya M, Chitukuta M, Guma V, Tenza S, Leslie J, Garcia M, Naidoo S. AIDS Behav; 2021 Jun 23; 25(6):1890-1900. PubMed ID: 33389318 [Abstract] [Full Text] [Related]
15. Acceptability and Use of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) During Breastfeeding in South Africa, Malawi, Zimbabwe, and Uganda. Stoner MCD, Hawley I, Mathebula F, Horne E, Etima J, Kemigisha D, Mutero P, Dandadzi A, Seyama L, Fabiano Z, Scheckter R, Noguchi L, Owor M, Balkus JE, Montgomery ET. AIDS Behav; 2023 Dec 23; 27(12):4114-4123. PubMed ID: 37432541 [Abstract] [Full Text] [Related]
17. Self-reported removal and expulsion of the dapivirine vaginal ring: qualitative reports from female ring users and their male partners in the Ring Study (IPM 027). Milford C, Ramlal H, Mofokeng R, Rambally Greener L, Nel A, Smit J, Malherbe M. BMC Public Health; 2024 May 31; 24(1):1458. PubMed ID: 38822304 [Abstract] [Full Text] [Related]
20. Efficacy and Action of the Dapivirine Vaginal Ring as Understood by Women Participating in an Open Label Extension Study. Naidoo K, T ME, Katz AW, Morgan G, Krishnaveni R, Lydia ST, Sarita N, Leila ME. AIDS Behav; 2023 Jan 31; 27(1):75-81. PubMed ID: 35672549 [Abstract] [Full Text] [Related] Page: [Next] [New Search]